Clear All
12611 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
69076-0913-25 69076-0913 Mercaptopurine Mercaptopurine 50.0 mg/1 Chemotherapy Antimetabolite Purine Analog Oral Oct 5, 2016 Oct 31, 2024 No Longer Used
76346-0550-09 76346-0550 Relacorilant Lifyorli 25.0 mg/1, 100.0 mg/1 Chemotherapy Glucocorticoid Receptor (GR) Antagonist Oral Mar 25, 2026 In Use
43598-0047-28 43598-0047 SUNITINIB MALATE SUNITINIB MALATE 37.5 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FLT, PDGFR, KIT, RET, CSF Oral Nov 30, 2022 In Use
47335-0929-72 47335-0929 Temozolomide Temozolomide 140.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb 13, 2014 In Use
16729-0049-53 16729-0049 Temozolomide Temozolomide 20.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Mar 7, 2017 In Use
85001-0101-01 85001-0101 Zidesamtinib JIDEYTRO 25.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor ROS1, ALK, TRK Oral Jul 22, 2026 In Use
72237-0105-01 72237-0105 Selinexor XPOVIO 80.0 mg/1 Chemotherapy Enzyme Inhibitor XPO1 Oral Jan 5, 2026 In Use
70709-0191-12 70709-0191 Nilotinib CAVHANZA 60.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Jun 30, 2026 In Use
31722-0296-90 31722-0296 IMATINIB MESYLATE IMATINIB MESYLATE 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Apr 14, 2025 In Use
00069-4030-01 00069-4030 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Mar 5, 2013 Aug 31, 2021 No Longer Used
83634-0207-51 83634-0207 Cyclophosphamide Cyclophosphamide 2.0 g/100mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous, Oral Feb 1, 2026 In Use
63629-1472-05 63629-1472 Methotrexate sodium Methotrexate Sodium 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Dec 11, 2012 In Use
00069-0079-01 00069-0079 Paclitaxel Paclitaxel 30.0 mg/5mL Chemotherapy Antimitotic Agent Taxane Intravenous Sep 30, 2011 Dec 31, 2016 No Longer Used
00069-0227-03 00069-0227 Lorlatinib Lorbrena 25.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor ALK/ROS1 Oral Jan 3, 2025 Mar 31, 2027 In Use
00703-4156-11 00703-4156 Idarubicin Hydrochloride Idarubicin Hydrochloride 1.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Oct 1, 2002 Jan 31, 2024 No Longer Used
82249-0613-30 82249-0613 Everolimus Yulithira 10.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral Jun 11, 2026 In Use
72819-0152-95 72819-0152 Mitomycin Mitomycin 5.0 mg/10mL Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous Mar 11, 2022 In Use
23155-0213-31 23155-0213 Gemcitabine Hydrochloride Gemcitabine Hydrochloride 200.0 mg/5mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Oct 22, 2012 Aug 11, 2020 No Longer Used
72485-0213-15 72485-0213 Irinotecan Hydrochloride Irinotecan Hydrochloride 20.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Sep 4, 2020 In Use
00703-3675-01 00703-3675 Methotrexate Methotrexate 25.0 mg/mL Chemotherapy Antimetabolite Folic Acid Analog Intra-arterial, Intramuscular, Intrathecal, Intravenous Aug 1, 2012 In Use
00703-4636-01 00703-4636 Streptozocin Zanosar 100.0 mg/mL Chemotherapy Alkylating Agent Nitrosourea Intravenous Dec 3, 2003 In Use
52652-2001-06 52652-2001 Methotrexate Xatmep 2.5 mg/mL Chemotherapy Antimetabolite Folic Acid Analog Oral Aug 13, 2018 In Use
71288-0119-91 71288-0119 Decitabine Decitabine 50.0 mg/20mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jul 2, 2021 In Use
72205-0324-30 72205-0324 Dasatinib Dasatinib 140.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Sep 11, 2026 In Use
71335-1772-07 71335-1772 Methotrexate Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Dec 29, 2021 In Use

Found 12611 results — Export these results